abs252.txt	background		epstein-barr	virus	(ebv)-positive	gastric	cancers	represent	adistinct	subtype	of	gastric	cancers	and	account	for	nearly	10%	of	the	gastriccancer	burden		yet	risk	detection	strategies	for	this	cancer	subtype	are	lacking	methods		we	conducted	a	nested	case-control	study	where	we	assayed	4	ebv	antigens[viral	capsid	antigen	(vca)		early	antigen	(ea)		epstein-barr	nuclear	antigen(ebna)		and	bzlf1-encoded	replication	activator	protein	(zebra)]	in	either	seraor	plasma	from	1447	gastric	cancer	cases	and	1797	controls	obtained	from	sevenprospective	cohorts	representing	individuals	from	the	high	gastric	cancer-riskcountries	of	china		japan		and	korea	results		the	prevalence	of	ebv	sero-positivity	was	universal	with	the	exceptionof	one	sero-negative	individual		and	the	highest	titers	of	the	ebv	antigens	vca(or	0	95		95%	ci	0	78-1	17)		ebna	(or	0	88		95%	ci	0	72-1	08)		ea	(or	0	97		95%ci	0	79-1	19)		and	zebra	(or	0	87		95%	ci	0	71-1	07)	were	not	associated	withrisk	of	incident	gastric	cancer		when	we	stratified	these	data	by	h		pyloristatus		there	was	no	change	in	the	association	conclusions		multiplex	serology	of	the	aforementioned	ebv	antigens	in	serum	maynot	be	a	suitable	biomarker	for	predicting	gastric	cancer	risk	in	east	asianpopulations	
